TILs

June 8, 2018

New Immunotherapy Rid Patient of Cancer in Breast, Everywhere Else, Study Reports

News

A new immunotherapy method that targets a patient’s tumor cell mutations led to a complete and lasting regression of breast cancer in a woman who had failed all other treatments, a ... Read more

October 10, 2014October 13, 2014

Tumor-Infiltrating Lymphocytes Can Be Used In Breast Cancer Diagnosis

News

Tumor-infiltrating lymphocytes (TILs) can be used to treat cancer and has prognostic/predictive indicators. Solid tumors are made of several components such as malignant cells and endothelial cells, as well as ... Read more

August 6, 2014August 6, 2014

PD-L1 Biomarker May Advance Immunotherapy Treatment For Early Stage Breast Cancer

Breast Cancer News, News

A newly developed molecular assay, PD-L1, was used to detect the levels of an important biomarker for immunotherapy in treating early stage breast cancers. Because the programmed death ligand/receptor1 (PD-1/PD-L1) axis ... Read more